-
FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 08-30-2026 TO 09-05-2026
I’m excited to announce the release of my latest FREE bio tech stock catalyst report for the upcoming week. This new FREE stock report highlights bio tech companies that have an important upcoming event and an expected price move of 20 percent up or down ($ +/- 20%) to help you make informed market decisions.…
-
Groundbreaking Clinical Results for Intranasal Foralumab Published by Tiziana Life Sciences
NASDAQ: $TLSA Tiziana Life Sciences plc recently announced a significant milestone in their ongoing research and development efforts: the peer-reviewed publication of clinical study results concerning their lead product candidate, intranasal Foralumab. This publication, detailed in a press release issued on January 20, 2026, marks a crucial step forward in validating the potential of this…